KRMD KORU Medical Systems, Inc.
KORU Medical Systems, Inc. (KRMD) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.00 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.8% since its last earnings release on August 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About KORU Medical Systems, Inc.
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.
Sector
Healthcare
Industry
Medical Appliances/Equipment